(Q43550814)

English

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT. (English)

1 reference

Europe PubMed Central

24 November 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

24 November 2017

author name string

A Spyridonidis

1

1 reference

Europe PubMed Central

24 November 2017

M Labopin

2

1 reference

Europe PubMed Central

24 November 2017

C Schmid

3

1 reference

Europe PubMed Central

24 November 2017

L Volin

4

1 reference

Europe PubMed Central

24 November 2017

I Yakoub-Agha

5

1 reference

Europe PubMed Central

24 November 2017

M Stadler

6

1 reference

Europe PubMed Central

24 November 2017

N Milpied

7

1 reference

Europe PubMed Central

24 November 2017

G Socie

8

1 reference

Europe PubMed Central

24 November 2017

S Lenhoff

10

1 reference

Europe PubMed Central

24 November 2017

M A Sanz

11

1 reference

Europe PubMed Central

24 November 2017

M Aljurf

12

1 reference

Europe PubMed Central

24 November 2017

M Mohty

13

1 reference

Europe PubMed Central

24 November 2017

V Rocha

14

1 reference

Europe PubMed Central

24 November 2017

Immunotherapy Subcommittee of Acute Leukemia Working Party

15

1 reference

Europe PubMed Central

24 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 January 2012

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

26

1 reference

Europe PubMed Central

24 November 2017

6

1 reference

Europe PubMed Central

24 November 2017

1211-1217

1 reference

Europe PubMed Central

24 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2011.351

0 references

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

The EBMT activity survey 2008: impact of team size, team density and new trends

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Relapse after allogeneic hematopoietic cell therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapeutic strategies for the treatment of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.351

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2011.351

1 reference

Europe PubMed Central

24 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43550814&oldid=2098256039"